Abstract
The large number of deaths in newborns resulting from invasive early-onset group B streptococcal (GBS) disease constitutes a grave challenge. The apparent absence of this affliction in our institution appears to be a dividend of the routine use of penicillin for the prophylaxis of ophthalmia neonatorum in all newborns since 1952. Significant confirmation of the efficacy of parenteral penicillin therapy for this purpose derives from a recent report from Halifax in Canada. It is concerned with 983 newborns weighing less than 2,500 gm at birth in whom no deaths occurred during the study period. This contrasted with ten deaths due to GBS disease in 1,208 similar infants in the preceding year when penicillin was not administered.
- Copyright © 1978 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
